AbbVie ABBV
NYSE ABBV
$265.59 +3.76 (+1.44%)
As of: Aug 21, 2026 · 2:17 PM EDT

AbbVie (ABBV) Return on Sales (2012 - 2026)

AbbVie (ABBV) posted quarterly Return on Sales of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and down 57.46% quarter-over-quarter from 0.0% in Q4 2025.

AbbVie (ABBV) Return on Sales (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported Return on Sales for 15 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
  • Return on Sales retreated to 0.0% in Q1 2026 per ABBV's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.0% in Q1 2022 and bottomed at 0.0% in Q1 2023.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2025.
  • On a YoY basis, Return on Sales climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
  • AbbVie's Return on Sales stood at 0.0% in 2022, then tumbled by 65 bps to 0.0% in 2023, then plunged by 103 bps to 0.0% in 2024, then surged by 7271 bps to 0.0% in 2025, then slumped by 57 bps to 0.0% in 2026.
  • Business Quant data shows ABBV's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Johnson & Johnson 653.03 Bn 632.27 Bn 17.26 Bn 0.00%
2 AbbVie 469.62 Bn 463.05 Bn 12.70 Bn 0.00%
3 Merck 375.00 Bn 367.85 Bn 12.21 Bn 0.00%
4 Novartis Ag 303.31 Bn 295.62 Bn 11.24 Bn 0.00%
5 Astrazeneca 257.68 Bn 252.78 Bn 12.86 Bn 0.00%
6 Amgen 236.34 Bn 222.35 Bn 7.24 Bn 0.00%
7 Gilead Sciences 182.09 Bn 178.91 Bn 6.22 Bn -0.01%
8 Pfizer 159.43 Bn 147.73 Bn 10.94 Bn 0.00%
9 Gsk 106.25 Bn 102.08 Bn 8.24 Bn 0.00%
10 Sanofi 55.19 Bn 47.81 Bn 10.79 Bn 0.01%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00%
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%